PARTNERSHIP OPPORTUNITIES
The commercial and therapeutic potential of peptide-based therapies is accelerating from concept to clinic like never before. However, the leading drug developer organizations in this field are telling us that they have little visibility of which contract service providers have the technical experience, capacity, and flexibility to meet their demands.
PEPTIDE-BASED DRUG DEVELOPERS NEED YOUR HELP WITH:
AI/ML technologies, quantum computing & cloud-based technologies that enable the prediction of peptide drug structure, function and folding, as well as biasing screening towards peptide discovery with enhanced stability or cell permeability
Fast, efficacious and cost-effective high throughput screening and parallel synthesis of compounds that combine experimental methods to test and optimize computational hits
Designing orally bioavailable peptides with formulation that maintains optimized pharmacokinetic properties, absorption and intracellular targeting
R&D scale peptide synthesis and clinical scale up of manufacturing with green chemistry to accelerate novel peptide drugs from concept to clinic and beyond
Analytical physiochemical and bioassays to verify and confirm peptide product properties, cell permeable functionality to ensure product quality and purity, particularly as the space gains pipeline momentum
...and more!
WHO WILL YOU MEET?
Senior decision-makers at leading large pharma and biotech will come together in Boston at the 2nd Peptide-Based Therapeutics Summit, actively seeking to collaborate with organizations that can help them accelerate their peptide-based drugs.
Make the most of the varied networking opportunities on offer to build vital relationships for the future, showcase your solutions, generate new business leads, and source opportunities for partnerships.
ACT NOW TO STAY AHEAD OF THE CURVE AND SEIZE THE WEALTH OF OPPORTUNITY ON OFFER
